Mark Joseph Ajalat

Mark Ajalat practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Mark Ajalat's NPI, 1487158168, was assigned on March 19, 2018. Mark Ajalat graduated from UC Irvine School of Medicine in 2019. Mark Ajalat's California license number on file is A164475.

Mark Ajalat's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Mark Ajalat's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Mark Ajalat is also affiliated with Olive View-UCLA Medical Center. The medical group on file is UCLA Gonda (Goldschmied) Vascular Center. Dmand AI also links Mark Ajalat to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Ajalat practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Mark Ajalat's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Mark Ajalat is board certified in vascular surgery by the American Board of Surgery. Mark Ajalat has a license on file in California.

CMS data shows 171 Medicare services from Mark Ajalat across 2 procedure codes in 2024, for 38 Medicare patients. Medicare paid $15,378 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Mark Ajalat in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Ajalat's median patient age at 63, with 39% women.

In 2022, Mark Ajalat wrote 25 Medicare Part D claims. They cover 2 drugs, with $166 in total drug cost. In 2021, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Mark Ajalat for performance year 2024, reported as part of a group. Mark Ajalat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Ajalat as offering telehealth.

Dmand AI links 1 paper to Mark Ajalat in 2018. Mark Ajalat's most frequent co-author is Samuel Eric Wilson, MD.

CMS Open Payments shows 114 general payments to Mark Ajalat from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 90% of the total. W. L. Gore & Associates, Inc. paid the most, $3,052.

Mark Ajalat graduated from UC Irvine School of Medicine in 2019.

Mark Ajalat is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.